Combined Pap and HPV testing in primary screening for cervical abnormalities: Should HPV detection be delayed until age 35?

European Journal of Cancer

Volumn 41, Issue 17, 2005, Pages 2704-2708

  Baay, Marc F D ^a   Tjalma, Wiebren A A ^a   Lambrechts, Hilde A J ^a   Pattyn, Greet G O ^a   Lardon, Filip ^a   Weyler, Joost ^a   Van Royen, Paul ^a   Van Marck, Eric A E ^a   Vermorken, Jan B ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cervical cancer; Human papillomavirus; Primary screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS DETECTION; WART VIRUS;

ADULT; AGE DISTRIBUTION; AGE FACTORS; BELGIUM; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; UTERINE CERVICAL DISEASES; VAGINAL SMEARS;

EID: 27744441742     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.04.050     Document Type: Article

References (22)

1. P.W. Melkert, E. Hopman, and A.J. van den Brule Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent Int J Cancer 53 6 1993 919 923
2. J. Cuzick, A. Szarewski, and G. Terry Human papillomavirus testing in primary cervical screening Lancet 345 8964 1995 1533 1536
3. R.D. Burk, P. Kelly, and J. Feldman Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors Sex Transm Dis 23 4 1996 333 341
4. A.M. de Roda Husman, J.M. Walboomers, and E. Hopman HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern J Med Virol 46 2 1995 97 102
5. C. Clavel, J.P. Bory, and S. Rihet Comparative analysis of human papillomavirus detection by hybrid capture assay and routine cytologic screening to detect high-grade cervical lesions Int J Cancer 75 4 1998 525 528
6. M.V. Jacobs, J.M. Walboomers, and P. Snijders Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types Int J Cancer 87 2 2000 221 227
7. J. Cuzick, P. Sasieni, and P. Davies A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions Br J Cancer 83 5 2000 561 565
8. G.Y. Ho, R. Bierman, and L. Beardsley Natural history of cervicovaginal papillomavirus infection in young women New Engl J Med 338 7 1998 423 428
9. C.B. Woodman, S. Collins, and H. Winter Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 9271 2001 1831 1836
10. A.R. Giuliano, R. Harris, and R.L. Sedjo Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the young women's health study J Infect Dis 186 4 2002 462 469
11. K. Elfgren, M. Kalantari, and B. Moberger A population-based five-year follow-up study of cervical human papillomavirus infection Am J Obstet Gynecol 183 3 2000 561 567
12. R.K. Saiki, D.H. Gelfand, and S. Stoffel Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase Science 239 4839 1988 487 491
13. A.M. de Roda Husman, J.M. Walboomers, and A.J. van den Brule The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR J Gen Virol 76 Pt. 4 1995 1057 1062
14. M.V. Jacobs, A.J. van den Brule, and P.J. Snijders A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR J Med Virol 49 3 1996 223 229
15. K.U. Petry, S. Menton, and M. Menton Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients Br J Cancer 88 10 2003 1570 1577
16. O. Forslund, A. Antonsson, and K. Edlund Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women J Med Virol 66 4 2002 535 541
17. K.S. Cuschieri, H.A. Cubie, and M.W. Whitley Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population J Clin Pathol 57 1 2004 68 72
18. C.E. Depuydt, A.J. Vereecken, and G.M. Salembier Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women Br J Cancer 88 2003 560 566
19. P. Clarke, C. Ebel, and D.N. Catotti The psychosocial impact of human papillomavirus infection: implications for health care providers Int J STD AIDS 7 3 1996 197 200
20. J.E. Ramirez, D.M. Ramos, and L. Clayton Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women J Womens Health 6 1 1997 113 121
21. F. Fylan Screening for cervical cancer: A review of women's attitudes, knowledge, and behaviour Br J Gen Pract 48 433 1998 1509 1514
22. M.F.D. Baay, E. Smits, and W.A.A. Tjalma Can cervical cancer screening be stopped at 50: the prevalence of HPV in elderly women Int J Cancer 108 2 2004 258 261